Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Glivec (imatinib mesylate) in the treatment of polycythemia vera

Trial Profile

Glivec (imatinib mesylate) in the treatment of polycythemia vera

Phase of Trial: Phase II

Latest Information Update: 07 Oct 2014

At a glance

  • Drugs Imatinib (Primary)
  • Indications Polycythaemia vera
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Jun 2012 Actual patient number is 9 according to ClinicalTrials.gov.
    • 18 Jun 2012 Actual end date (Feb 2010) added as reported by ClinicalTrials.gov.
    • 18 Jun 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top